RTN4R and Glucose intolerance: Four weeks’ treatment of NGR1 to diabetic mice significantly improved glucose intolerance as compared to STZ-treated mice without any changes in the weight of the mice (Figures 1C–E) The blood glucose of NGR1-treated diabetic mice was significantly lower than the vehicle-treated diabetic mice (p < 0.05, Figures 1C, D).